Shares of Evoke plc (LON:EVOK – Get Free Report) fell 10% on Thursday . The company traded as low as GBX 50.20 ($0.65) and last traded at GBX 51.73 ($0.67). 65,066,164 shares were traded during trading, an increase of 1,994% from the average session volume of 3,107,171 shares. The stock had previously closed at GBX 57.45 ($0.74).
Analysts Set New Price Targets
EVOK has been the subject of a number of recent research reports. Berenberg Bank decreased their price target on shares of Evoke from GBX 130 ($1.68) to GBX 90 ($1.16) and set a “buy” rating for the company in a research note on Wednesday, December 4th. Jefferies Financial Group reaffirmed a “buy” rating and set a GBX 140 ($1.81) price objective on shares of Evoke in a research report on Monday, December 16th.
View Our Latest Research Report on EVOK
Evoke Stock Performance
Evoke (LON:EVOK – Get Free Report) last released its quarterly earnings data on Wednesday, March 26th. The company reported GBX (6.40) (($0.08)) earnings per share for the quarter. Evoke had a negative return on equity of 517.98% and a negative net margin of 8.50%. Research analysts anticipate that Evoke plc will post 12.7648305 earnings per share for the current year.
Insider Buying and Selling at Evoke
In other news, insider Andrea Gisle Joosen acquired 14,572 shares of the firm’s stock in a transaction dated Tuesday, January 28th. The stock was acquired at an average cost of GBX 70 ($0.91) per share, with a total value of £10,200.40 ($13,202.69). 27.00% of the stock is currently owned by insiders.
Evoke Company Profile
Further Reading
- Five stocks we like better than Evoke
- How to Invest in Tech Stocks and Top Tech Stocks to Consider
- MarketBeat Week in Review – 03/24 – 03/28
- Investing in Commodities: What Are They? How to Invest in Them
- Should You Buy UPS Stock Now? Deep Dive Into Its 5-Year Low
- 5 Top Rated Dividend Stocks to Consider
- 4 Healthcare Stocks With Massive Gains—and More to Come
Receive News & Ratings for Evoke Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evoke and related companies with MarketBeat.com's FREE daily email newsletter.